Effects of bortezomib on pro-inflammatory cytokine levels and transfusion dependency in a patient with multicentric Castleman disease.
Hess
Georg
G
Wagner
Volker
V
Kreft
Andreas
A
Heussel
Claus Peter
CP
Huber
Christoph
C
D001803:Blood Transfusion; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D005871:Castleman Disease / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000276:immunology; D008875:Middle Aged; D011480:Protease Inhibitors / Q000627:therapeutic use*; D011719:Pyrazines / Q000627:therapeutic use*; D016896:Treatment Outcome
D001897:Boronic Acids; D015850:Interleukin-6; D011480:Protease Inhibitors; D011719:Pyrazines; D000069286:Bortezomib